Match each epidemiological study scenario with the most accurate type of research bias or confounding it describes.
- A retrospective analysis concludes that patients receiving a novel biological agent for rheumatoid arthritis have a higher rate of opportunistic infections. However, the novel agent is clinically reserved only for patients with highly refractory, severe disease.Confounding by indication
- A public health initiative implements an ultrasensitive serum marker for early detection of an aggressive neoplasm. The program reports a significant increase in mean survival time from diagnosis, yet population-level mortality rates for the disease remain unchanged.Lead-time bias
- A researcher investigating the link between NSAID use and peptic ulcer disease selects both cases and controls entirely from the inpatient wards of a tertiary care hospital, distorting the exposure-disease odds ratio compared to the general population.Berkson bias
- In a trial for a new psychiatric medication, investigators subconsciously assign more favorable subjective rating scores to participants they suspect are receiving the active drug, cued by the presence of known anticholinergic side effects.Observer-expectancy bias
Answer
The rheumatoid arthritis scenario matches confounding by indication. The cancer screening scenario matches lead-time bias. The NSAID hospital study matches Berkson bias. The psychiatric medication trial matches observer-expectancy bias.
The study scenarios each represent a classic form of bias or confounding encountered in medical research. Confounding by indication occurs when the patient's underlying disease severity dictates the treatment choice and independently affects the outcome. Lead-time bias creates a false impression of increased survival due to earlier diagnosis without altering the disease's terminal point. Berkson bias, a form of selection bias, arises when study groups are chosen from a hospital population where admission rates for the exposure and disease differ from the general population. Observer-expectancy bias (Pygmalion effect) occurs when the researcher's belief in the efficacy of a treatment consciously or subconsciously influences their measurement of subjective outcomes, often unmasked by identifiable side effects.
Step-by-Step Solution
Key Concept
Identification and differentiation of epidemiological biases based on study design and clinical scenarios.
Estimated Time:2m 0s